Fusion Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 83.8M shares, a 55.8% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 65.6M shares, a 50% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 43.7M shares, a 2.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 83.8M +30M +55.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 65.6M +21.9M +50% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 69.1M +25.4M +58.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 66.3M +22.9M +52.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 53.8M +10.6M +24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 43.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 43.7M +661K +1.54% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 43.4M +856K +2.01% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 43.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 43M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 42.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.